These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29184688)

  • 1. Age and factors associated with access and time to post-operative adjuvant chemotherapy in colon cancer: a French epidemiological study.
    Capsec J; Lefebvre C; Chupé F; Heitzmann P; Raveneau C; Dardaine-Giraud V; Sauger C; Lagasse JP; Kraft K; Linassier C; Dorval E
    J Gastrointest Oncol; 2017 Oct; 8(5):842-849. PubMed ID: 29184688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
    Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO
    J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adequacy of the National Quality Forum's Colon Cancer Adjuvant Chemotherapy Quality Metric: Is 4 Months Soon Enough?
    Massarweh NN; Haynes AB; Chiang YJ; Chang GJ; You YN; Feig BW; Cormier JN
    Ann Surg; 2015 Aug; 262(2):312-20. PubMed ID: 25185467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
    Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
    Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications after discharge and delays in adjuvant chemotherapy following colonic resection: a cohort study of linked primary and secondary care data.
    Arhi CS; Burns EM; Bouras G; Aylin P; Ziprin P; Darzi A
    Colorectal Dis; 2019 Mar; 21(3):307-314. PubMed ID: 30537049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiation of adjuvant chemotherapy within 8 weeks of elective colorectal resection improves overall survival regardless of reoperation.
    Nachiappan S; Askari A; Mamidanna R; Munasinghe A; Currie A; Stebbing J; Faiz O
    Colorectal Dis; 2016 Nov; 18(11):1041-1049. PubMed ID: 27807941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
    Sarasqueta C; Perales A; Escobar A; Baré M; Redondo M; Fernández de Larrea N; Briones E; Piera JM; Zunzunegui MV; Quintana JM;
    BMC Cancer; 2019 Jul; 19(1):735. PubMed ID: 31345187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reasons for Underuse of Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer.
    Ko JJ; Kennecke HF; Lim HJ; Renouf DJ; Gill S; Woods R; Speers C; Cheung WY
    Clin Colorectal Cancer; 2016 Jun; 15(2):179-85. PubMed ID: 26520019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant Chemotherapy and Tumor Sidedness in Stage II Colon Cancer: Analysis of the National Cancer Data Base.
    Mukkamalla SKR; Huynh DV; Somasundar PS; Rathore R
    Front Oncol; 2020; 10():568417. PubMed ID: 33042845
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
    Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
    Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcome of adjuvant chemotherapy in deficient mismatch repair stage III colon cancer.
    Shaib WL; Zakka KM; Jiang R; Yan M; Alese OB; Akce M; Wu C; Behera M; El-Rayes BF
    Cancer; 2020 Sep; 126(18):4136-4147. PubMed ID: 32697360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Population-Based Cohort Study of Venous Thromboembolism Rates Following Surgery and During Adjuvant Chemotherapy in Patients With Colon Cancer.
    Patel SV; Zhang L; Wei XS; Merchant SJ; Nanji S; James PD; Booth CM
    Dis Colon Rectum; 2020 Mar; 63(3):336-345. PubMed ID: 32045399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of adjuvant chemotherapy among stage III colon cancer patients at a public versus private hospital in New York City.
    Lin D; Goldberg JD; Hochman T; Levinson BA; Khan M; Newman E; Leichman LP; Gold HT
    Cancer Causes Control; 2018 Feb; 29(2):253-260. PubMed ID: 29250702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic colectomy for cancer: Improved compliance with guidelines for chemotherapy and survival.
    Kim RH; Kavanaugh MM; Caldito GC
    Surgery; 2017 Jun; 161(6):1633-1641. PubMed ID: 28027818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timeliness of adjuvant chemotherapy for stage III adenocarcinoma of the colon: a measure of quality of care.
    Yu S; Shabihkhani M; Yang D; Thara E; Senagore A; Lenz HJ; Sadeghi S; Barzi A
    Clin Colorectal Cancer; 2013 Dec; 12(4):275-9. PubMed ID: 24188686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
    Ejaz A; Casadaban L; Maker AV
    J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.
    Peixoto RD; Kumar A; Speers C; Renouf D; Kennecke HF; Lim HJ; Cheung WY; Melosky B; Gill S
    Clin Colorectal Cancer; 2015 Mar; 14(1):25-30. PubMed ID: 25465343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of timing of adjuvant chemotherapy following radical cystectomy for bladder cancer on patient survival.
    Grunewald CM; Henn A; Galsky MD; Plimack ER; Harshman LC; Yu EY; Crabb SJ; Pal SK; Alva AS; Powles T; De Giorgi U; Agarwal N; Bamias A; Ladoire S; Necchi A; Vaishampayan UN; Sternberg CN; Bellmunt J; Baniel J; Niegisch G
    Urol Oncol; 2020 Dec; 38(12):934.e1-934.e9. PubMed ID: 32660788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon Cancer.
    Kim CW; Kim TW; Lee JL; Park IJ; Yoon YS; Lim SB; Yu CS; Kim JC
    Clin Colorectal Cancer; 2020 Dec; 19(4):e157-e163. PubMed ID: 32896486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N1c colon cancer and the use of adjuvant chemotherapy: a current audit of the National Cancer Database.
    Simon HL; Reif de Paula T; Spigel ZA; Keller DS
    Colorectal Dis; 2021 Mar; 23(3):653-663. PubMed ID: 33064353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.